FREE Account Opening + No Clearing Fees
Loading...
Dipna Pharmachem Rights Issue 2024 Detail
Issue Open February 26, 2024
Issue Close March 20, 2024
Issue Size (Shares) 1.30 Crores
Issue Size (Amount) ₹12.97 Crores
Issue Price ₹10 per Share
Listing At BSE
  1. BSE-listed pharma stock to soon announce twin corporate events of bonus and split

    April 10, 2024 3:56:00 PM

    After a rights issue earlier in February this year, pharma stock Dipna Pharmachem will soon announce twin corporate actions of bonus distribution and sub-division of the face value of equities.

    Published by : India TV
  2. Stock Split, Bonus: Dipna Pharmachem to Declare Two Corporate Actions Soon

    April 9, 2024 12:39:00 PM

    Stock Split, Bonus: Pharmaceuticals company Dipna Pharmachem will soon announce two ... "The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company," it ...

    Published by : Times Now on MSN
  3. Stock split, bonus shares: This pharma company may announce two corporate actions - Check details

    April 10, 2024 1:52:00 AM

    "Dipna Pharmachem Limited's decision to undertake a stock split and bonus issue is a strategic move aimed at enhancing shareholder value, increasing liquidity, and signalling confidence in the company ...

    Published by : Zee Business
  4. Dipna Pharmachem Limited to Announce Stock Split And Bonus Shares | Check Key Details Here

    April 9, 2024 2:39:00 PM

    New Delhi: Dipna Pharmachem Limited, a prominent player in the pharmaceutical trading sector, has revealed its intention to issue bonus equity shares to existing shareholders and initiate a sub ...

    Published by : India.com on MSN
  5. Mawson�s Subsidiary SXG Announces A$10.23 Million Fully Underwritten Rights Issue

    April 4, 2024 7:50:00 PM

    Mawson intends to cornerstone the Rights Issue through acquiring its full entitlement as a 50.5% shareholder of SXG. The Rights Issue is to raise A$10,232,848 with one (1) new fully paid ordinary ...

    Published by : Miami Herald
  6. Dipna Pharmachem Ltd Share Price

    April 19, 2024 3:30:00 AM

    Dipna Pharmachem Ltd share price was up by 12.01% from the previous closing price of ?8.16. Who are peers of Dipna Pharmachem Ltd? The peers of Dipna Pharmachem Ltd are Adani Enterprises Ltd ...

    Published by : Business Today
  7. Top Europe rights court to issue landmark climate verdicts

    April 7, 2024 4:33:00 AM

    Europe's top rights court will on Tuesday issue unprecedented verdicts in three separate cases on the responsibility of states in the face of global warming, rulings that could force governments ...

    Published by : Voice of America
  8. Committed to Rights

    April 11, 2024 9:38:00 PM

    Comstock, Audrey L. 2022. Negotiated rights: UN treaty negotiation, socialization, and human rights. Journal of Human Rights, Vol. 21, Issue. 4, p. 463. Comstock ...

    Published by : Cambridge University Press
  9. Issue of Equity and Total Voting Rights

    April 5, 2024 3:30:00 AM

    The issued share capital and total voting rights of the Company are now 52,910,031. This figure may be used by shareholders in the Company as the denominator for the calculations by which they ...

    Published by : Yahoo Finance
  10. LGBT Rights

    April 12, 2024 3:30:00 AM

    and transgender peoples' rights, and with activists representing a multiplicity of identities and issues. We document and expose abuses based on sexual orientation and gender identity worldwide ...

    Published by : Human Rights Watch
  11. Denial of abortion rights the new Jean Crow.

    April 11, 2024 12:52:00 PM

    Because full and equal rights for American women is a national � not state � issue, Congress must enact a law that protects women�s reproductive rights (�Arizona can enforce an 1864 law ...

    Published by : The Baltimore Sun

Read Dipna Pharmachem Rights Issue 2024 current news. Find Dipna Pharmachem Rights Issue 2024 subscription news, Rights Issue analysis, broker reviews, allotment news, and listing date. Get the Dipna Pharmachem Ltd. Rights Issue grey market premium and Dipna Pharmachem Rights Issue 2024 expected listing price.